Advocacy Actions

2015-01-19 > All chapters

Submit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation

Submit Comments/Recommendations to CFDA on the Draft Guidance for Medical Software Evaluation

Read more
2015-01-15 > Shanghai

Submit Comments/Recommendations to MOT on Disclosure of Repairing and Maintenance Information (RMI)

Submit Comments/Recommendations to MOT on Disclosure of Repairing and Maintenance Information (RMI)

Read more
2015-01-15 > All chapters

Meeting with China Association of Medical Equipment (CAME)

COCIR, MITA and CAME exchanged opinions about delelopmtent of the Medical Imaging Industry as well as "Buy China" Initatives of the NHFPC.

Read more
2015-01-15 > All chapters

Meeting with Medical Imaging & Technology Alliance (MITA)

COCIR and MITA agreed to have regular meetings (monthly) to 1) exchange industry updates 2) discuss joint efforts on concrete industry issues if it’s appropriate 3) align lobby points with the Chinese authorities, eg. for JCCT from US side, and EU-China Regulators Dialogue.

Read more
2015-01-14 > Shanghai

Meeting with Shanghai FTZ scholars

A meeting with FTZ scholars to discuss the recent developments of the Shanghai FTZ.

Read more
2015-01-14 > All chapters

Meeting with Japanese Chamber of Commerce Life Science Group on Position Paper

Exchange of opinions on the position papers medical devices / life science of the two chambers

Read more
2015-01-13 > Shanghai

Meeting with Jean-Marie AVEZOU on Euro Tour

Update of Arrangement of Euro Tour and Meeting with MOT

Read more
2015-01-13 > All chapters

Submit Comments/Recommendations to CFDA Different Departments jointly with CAMDI

Submit Comments/Recommendations to CFDA Different Departments jointly with CAMDI

Read more
2015-01-12 > Shanghai

Meetings with MOT on the Disclosure of Repairing and Maintenance Information (RMI)

Discussion on the Disclosure of Repairing and Maintenance Information (RMI)

Read more
2015-01-09 > Beijing, Shanghai

Cosmetics Working Group Meeting

We organized the working group meeting on 9 Jan., with participation of Director Qi from Department of Drug and Cosmetics Registration, CFDA.

Read more